Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.
University of Texas Southwestern, Medical School, Dallas, TX.
Urol Oncol. 2019 Oct;37(10):758-764. doi: 10.1016/j.urolonc.2019.06.009. Epub 2019 Aug 2.
To identify preoperative risk factors for disease recurrence, following radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC), and to create a predictive nomogram.
Based on a multicenter database, we identified patients who underwent RNU due to high grade UTUC. Urothelial carcinoma of the bladder or contralateral UTUC was not considered as recurrence. Cox regression model was used to determine the effect of different preoperative variables as predictors of recurrence.
Two hundred and forty-five patients were included in the analysis. The 2 and 5 years recurrence rates were 16.3% and 19.2%, respectively. Factors associated with recurrence on univariable analysis were sessile architecture hazard ratio (HR) 3.16 (95% CI, 1.38-7.26, P = 0.006), ≥cT3 disease HR 2.30 (95% CI, 1.12-4.72, P= 0.023), age >65 HR 2.02 (95% CI, 1.00-4.05, P= 0.048), Eastern Cooperative Group > 0 HR 1.98 (95% CI, 1.09-3.57, P= 0.023), hydronephrosis HR 1.93 (95% CI, 1.04-3.57, P= 0.035). Higher hemoglobin levels HR 0.81 (95% CI, 0.69-0.96, P= 0.013) and preoperative estimated glomerular filtration rate ≥ 50 HR 0.48 (95% CI, 0.25-0.92, P = 0.028) were associated with lower probability for recurrence. Multivariable analysis identified sessile architecture as the only independent predictor of recurrence HR 2.52 (95% CI, 1.09-5.86, P= 0.0308). C-index of 0.71 was calculated for a predictive model including all variables in the multivariable analysis, indicating good predictive accuracy. A nomogram predicting 2 and 5 year recurrence free probability was developed accordingly.
Based on a multicenter database, we developed a nomogram with good predictive accuracy for recurrence following RNU. This may serve as an aid in decision-making regarding the use of neoadjuvant chemotherapy.
确定根治性肾输尿管切除术(RNU)治疗上尿路上皮癌(UTUC)后疾病复发的术前危险因素,并建立预测列线图。
基于多中心数据库,我们确定了因高级别 UTUC 而行 RNU 的患者。膀胱癌或对侧 UTUC 不作为复发考虑。使用 Cox 回归模型确定不同术前变量作为复发预测因子的影响。
245 例患者纳入分析。2 年和 5 年复发率分别为 16.3%和 19.2%。单变量分析中与复发相关的因素为无蒂结构[危险比(HR)3.16(95%可信区间,1.38-7.26,P=0.006)]、≥cT3 疾病(HR 2.30,95%可信区间,1.12-4.72,P=0.023)、年龄>65 岁(HR 2.02,95%可信区间,1.00-4.05,P=0.048)、东部合作肿瘤组(ECOG)评分>0(HR 1.98,95%可信区间,1.09-3.57,P=0.023)、肾积水(HR 1.93,95%可信区间,1.04-3.57,P=0.035)。较高的血红蛋白水平(HR 0.81,95%可信区间,0.69-0.96,P=0.013)和术前估算肾小球滤过率≥50ml/min(HR 0.48,95%可信区间,0.25-0.92,P=0.028)与较低的复发概率相关。多变量分析确定无蒂结构是复发的唯一独立预测因子(HR 2.52,95%可信区间,1.09-5.86,P=0.0308)。包含多变量分析中所有变量的预测模型的 C 指数为 0.71,表明具有良好的预测准确性。相应地开发了一个预测 2 年和 5 年无复发生存率的列线图。
基于多中心数据库,我们开发了一个具有良好预测准确性的 RNU 后复发预测列线图。这可能有助于在使用新辅助化疗方面做出决策。